Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.31 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15996697 | 0.84 | — | — | |
| SCHEMBL18459964 | 0.83 | SMN1; SMN2 (0.35) | SMN1; SMN2CA14CA12CA1CA2 | |
| SCHEMBL19449350 | 0.82 | CA1 (0.39) | SMN1; SMN2CA1CA2 | |
| SCHEMBL284234 | 0.82 | — | — | |
| SCHEMBL10240193 | 0.81 | — | — | |
| SCHEMBL2760523 | 0.81 | CA1 (0.37) | SMN1; SMN2CA14CA12CA1CA2 | |
| SCHEMBL13784620 | 0.81 | CA1 (0.37) | SMN1; SMN2CA14CA12CA1CA2 | |
| SCHEMBL19496142 | 0.80 | — | — | |
| SCHEMBL22810787 | 0.80 | CA1 (0.35) | CA1CA2CA7LMNA | |
| SCHEMBL10069151 | 0.80 | ALDH1A1 (0.39) | LMNAMMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159488-A1 | APPLICATION OF HETEROCYCLIC COMPOUND CONTAINING AT LEAST TWO SULFUR ATOMS IN PREPARING NANO-VACCINE AND PREPARED NANO-VACCINE | Suzhou WEAST Biotechnology Co., Ltd. (CN) | 2023-05-25 | — | — | US | disclosed |
| US-9796803-B2 | Under layer film-forming composition for imprints and method of forming pattern | FUJIFILM CORPORATION (JP) | 2017-10-24 | — | — | US | disclosed |
| EP-2321233-B1 | DISPERSING AGENTS FOR GYPSUM PLASTER COMPOSITIONS | SIKA TECH AG (CH) | 2017-03-22 | — | — | EP | disclosed |
| US-9540513-B2 | Lignocellulosic article and method of producing same | BASF SE (DE) | 2017-01-10 | — | — | US | disclosed |
| US-20160327859-A1 | COLORING COMPOSITION, AND CURED FILM, COLOR FILTER, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, IMAGE DISPLAY DEVICE, AND DYE MULTIMER, EACH USING THE COLORING COMPOSITION | FUJIFILM CORPORATION (JP) | 2016-11-10 | — | — | US | disclosed |
| EP-1536285-B1 | Photosensitive composition, compound for use in the photosensitive composition, and pattern forming method using the photosensitive composition | FUJIFILM CORP (JP) | 2016-01-06 | — | — | EP | disclosed |
| US-9159356-B2 | Non-resonant two-photon absorption recording material, non-resonant polymer two-photon absorption optical information recording medium, and recording/reproducing method | FUJIFILM CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| US-9120288-B2 | Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method for preparing electronic device, and electronic device | FUJIFILM CORPORATION (JP) | 2015-09-01 | — | — | US | disclosed |
| US-20140142224-A1 | LIGNOCELLULOSIC ARTICLE AND METHOD OF PRODUCING SAME | BASF SE (DE) | 2014-05-22 | — | — | US | disclosed |
| US-20140053755-A1 | Cellulose Acylate Film, Retardation Film, Polarizer and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2014-02-27 | — | — | US | disclosed |
| EP-2269817-A1 | HYDROPHILIC MEMBER, FIN MEMBER, ALUMINUM FIN MEMBER, HEAT EXCHANGER AND AIR CONDITIONER | FUJIFILM Corporation (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-7811742-B2 | Lithographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100203451-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-08-12 | — | — | US | disclosed |
| US-7635554-B2 | Positive resist composition and pattern forming method | FUJIFILM CORPORATION (JP) | 2009-12-22 | — | — | US | disclosed |
| WO-2009121149-A1 | STABILIZED PHOTOCHROMIC | ADVANCED POLYMERIK PTY LTD (AU) | 2009-10-08 | — | — | WO | disclosed |
| EP-2011643-A2 | Planographic printing plate precursor and printing method using the same | FUJIFILM Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| US-20080318171-A1 | METHOD OF FORMING PATTERNS | FUJIFILM CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080268372-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080248421-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING METHOD | FUJIFILM CORPORATION (JP) | 2008-10-09 | — | — | US | disclosed |
| US-20070122741-A1 | Resist protective coating material and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159488-A1 | APPLICATION OF HETEROCYCLIC COMPOUND CONTAINING AT LEAST TWO SULFUR ATOMS IN PREPARING NANO-VACCINE AND PREPARED NANO-VACCINE | CD4, NFATC1, CTSA | SMN1; SMN2 3015/4885CA14 933/4885CA12 1054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.